Yourgene Health (YGEN) Share Price, News & Analysis

Company Overview

Yourgene Health Plc, a molecular diagnostic company, researches, develops, and commercializes gene analysis techniques for prenatal screening and other applications in the United Kingdom, rest of Europe, and internationally. It develops in vitro diagnostic products, such as IONA Test, a non-invasive pre-natal test (NIPT) for Down's syndrome, Edwards' syndrome, and Patau's Syndrome in pregnant women; Cystic Fibrosis Screening tests; Rapid Aneuploidy Analysis, a confirmatory diagnostic test carried out after amniocentesi; and Recurrent Pregnancy Loss, a PCR assay for the routine diagnosis of the six most common chromosomes related to pregnancy loss, as well as DPYD genotyping products. The company also offers Ranger, a technology platform for sample size selection and enrichment; Elucigene DPYD assay, a PCR test to predict a patient's response to a chemotherapy treatment; and Clarigene SARS-CoV-2 CE-IVD, a PCR assay used for routine COVID-19 testing. In addition, it provides genomic services; sample preparation and analysis tools; and bioinformatics and software products, as well as extraction for DNA, RNA/miRNA, and nucleons; quantification; genotyping; gene expression; methylation; and microarray services for clinical research organizations. The company was formerly known as Premaitha Health PLC and changed its name to Yourgene Health Plc in November 2018. Yourgene Health Plc was incorporated in 2000 and is headquartered in Manchester, the United Kingdom. As of September 8, 2023, Yourgene Health Plc operates as a subsidiary of Novacyt UK Holdings Limited.

Key Stats

• Today's Range: 0.52 to 0.52
• 50-Day Range: 0.52 to 0.52
• 52-Week Range: 0.19 to 5.73
• Volume: 13.15 million shs
• Average Volume: 21.98 million shs
• Market Capitalization: £16.43 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

YGEN Stock Analysis - Frequently Asked Questions

How have YGEN shares performed this year?

Yourgene Health's stock was trading at GBX 0.52 at the beginning of 2024. Since then, YGEN shares have increased by 0.0% and is now trading at GBX 0.52.
View the best growth stocks for 2024 here.

How do I buy shares of Yourgene Health?

Shares of YGEN stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What other stocks do shareholders of Yourgene Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Yourgene Health investors own include HSBC (HSBA), Imperial Brands (IMB), Antofagasta (ANTO), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), Barclays (BARC) and B&M European Value Retail (BME).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Diagnostics & Research
• Sub-Industry: N/A
• Current Symbol: LON:YGEN
• CUSIP: N/A
• CIK: N/A
• Web: www.yourgene-health.com
• Phone: 44 16 1667 6865
• Fax: N/A
• Employees: 253
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): GBX (0.01)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 77.52
• P/E Growth: 9
• Net Income: £-8,170,000.00
• Net Margins: -27.55%
• Pretax Margin: N/A
• Return on Equity: -27.06%
• Return on Assets: -6.71%

Debt

• Debt-to-Equity Ratio: 68.93
• Current Ratio: 1.37
• Quick Ratio: 1.17

Sales & Book Value

• Annual Sales: £29.67 million
• Price / Sales: 0.55
• Cash Flow: GBX 0.34 per share
• Price / Cash Flow: 1.53
• Book Value: GBX 4 per share
• Price / Book: 0.13

Miscellaneous

• Outstanding Shares: 3,190,000,000
• Free Float: N/A
• Market Cap: £16.43 million
• Optionable: Not Optionable
• Beta: 0.86